论文部分内容阅读
37例晚期肺癌接受平消胶囊合并化疗药物治疗,与同期单纯化疗的28例晚期肺癌对照,有效率分别是54.0%和35.7%(P>0.05)。治疗组化疗后外周血白细胞减少Ⅱ度以上发生率为43.2%,对照组为78.6%,有显著差异(P<0.01)。部分患者在服用平消胶囊前及2疗程后检测外周血 T 细胞亚群及 NK 细胞活性,发现服用平消胶囊2疗程后 OKT_4~+、OKT_4~+/OKT_8~+,均显著升高(P<0.01),NK 活性也明显增高(P<0.05)。提示:平消胶囊对晚期肺癌的化疗可能有一定的增效作用,能减轻血液毒副作用。通过提高化疗后患者外周血 NK 活性及部分纠正 T 细胞亚群的失衡状态,改善患者的细胞免疫功能,起到了补气扶正的作用。
Forty-seven patients with advanced lung cancer received Pingxiao capsule combined with chemotherapy drugs. Compared with 28 patients with advanced lung cancer treated with chemotherapy alone, the effective rates were 54.0% and 35.7%, respectively (P>0.05). The incidence of leukopenia in the peripheral blood of patients in the treatment group after chemotherapy was 43.2% and 78.6% in the control group. There was a significant difference (P<0.01). Some patients in the peripheral blood T cell subpopulation and NK cell activity were detected before and after the treatment of Pingxiao Capsule. It was found that OKT_4~+ and OKT_4~+/OKT_8~+ were significantly increased after taking Pingping Capsule for 2 cycles (P <0.01), NK activity was also significantly higher (P < 0.05). Tip: Pingxiao capsule may have a certain synergistic effect on chemotherapy for advanced lung cancer, and can reduce blood side effects. By improving the NK activity in peripheral blood of patients after chemotherapy and partly correcting the unbalanced state of T cell subsets, the patient’s cellular immune function is improved, which plays a role in reinforcing qi.